inflammatory%20bowel%20disease
INFLAMMATORY BOWEL DISEASE
Inflammatory bowel disease consists of ulcerative colitis and Crohn's disease.
Ulcerative colitis is a diffuse mucosal inflammation limited to the colon while Crohn's disease is a patchy, transmural inflammation that occurs in any part of the gastrointestinal tract.
The ileum and colon are the most frequently affected sites.

Patient Education

  • Audiovisual or suitable written information on IBD should be given
  • Stress the importance of adherence to therapy

Lifestyle Modification

Nutrition and Lifestyle Modification for Ulcerative Colitis
  • Cessation of smoking may prevent flaring of symptoms in patients with UC
  • Stress management programs may aid in the patients’ overall disease outlook
  • Patients are prone to malnutrition and may suffer detrimental effects from it
    • Decrease fiber intake during increased disease activity to reduce frequency of bowel movements
    • High fiber diets to be given only for those with involvement limited to the rectum
  • Nutritional support is adjunctive in patients who are malnourished or have a difficult time maintaining normal nutritional status and should also be considered in those with intestinal partial obstruction awaiting surgery
  • Prebiotics and probiotics have no clear evidence on its role as adjunctive therapy
  • Routine multivitamin supplementation for all patients
  • Routine vit D and Ca supplementation for those under steroid therapy
  • Iron supplementation, either oral or parenteral, for those with chronic iron deficiency

Nutrition and Lifestyle Modification for Crohn's Disease
  • Smoking cessation should be strongly advised
  • Stress management programs may aid in the patients’ overall disease outlook
  • Patients are prone to malnutrition and may suffer detrimental effects from it
    • Decrease fiber intake during increased disease activity to reduce frequency of bowel movements
    • Placing the patient on NPO, or giving only liquid diet or pre-digested formula may decrease obstructive symptoms
  • Elemental or polymeric diets may be used to induce remission in some patients with active CD who have contraindications to corticosteroids or where patients prefer to avoid corticosteroids
    • May reduce inflammatory features of active CD; although, long-term course of the disease is not altered
      • Cost and compliance may be a limiting factor
    • May be attempted as adjunctive therapy to support patient’s nutrition
  • Exclusive enteral nutrition is used as disease modifying therapy for growth failure
    • Usually given for 3-6 weeks
  • Nutritional support is adjunctive in patients who are malnourished or have a difficult time maintaining normal nutritional status, and should also be considered in those with intestinal partial obstruction awaiting surgery
  • Prebiotics and probiotics have no clear evidence on its role as adjunctive therapy
  • Routine multivitamin supplementation for all patients
  • Routine vit D and Ca supplementation for those under steroid therapy
  • Iron supplementation, either oral or parenteral, for those with chronic iron deficiency
  • Vit B12 supplementation for deficiency states at 1000 mcg SC every month 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
13 Mar 2017
The serum pepsinogen test—which is relatively simple, inexpensive, sensitive and specific—is a potentially viable method for the screening and detection of Kazakh early gastric cancer, a new study claims.
24 Apr 2017

Helicobacter pylori (H. pylori) infection is associated with conditions such as gastritis, peptic ulcer, gastric cancer, and certain types of lymphoma. A common presenting complaint among all these H. pylori-related illnesses is dyspepsia. Dr Desmond Wai from the Desmond Wai Liver and Gastrointestinal Diseases Centre, Mount Elizabeth Novena Specialist Centre, Singapore, speaks on the important role general practitioners (GPs) play in recognizing, diagnosing, and treating H. pylori.

Pearl Toh, 24 Nov 2016
New treatments such as pirfenidone and nintedanib slow lung function decline and progression of idiopathic pulmonary fibrosis (IPF), although response to treatment can vary dramatically among patients, according to a presentation at the 21st Congress of the Asian Pacific Society of Respirology (APSR 2016) held in Bangkok, Thailand.